ClinicalTrials.Veeva

Menu

ICU Mortality Predictors of Trauma Patients

B

Balikesir University

Status

Completed

Conditions

İntensive Care Unit

Treatments

Other: decesased patients

Study type

Observational

Funder types

Other

Identifiers

NCT03894111
2019/32

Details and patient eligibility

About

In this study, the data of the patients who were hospitalized due to trauma in intensive care unit (ICU) were examined in their first development. The mortality rate and the factors affecting mortality in these patients were determined

Full description

In this study, 107 trauma patients were examined. Patients were divided into two groups according to ICU results: survivors (Group 1) and deceased patients (Group2). Patients were rated in terms of age, Neutrophil lymphocyte ratio (NLR) , mean platelet volüme (MPV), lactat value, intensive care unit stay, APACHE 2 soring systems. Mortality rate and the factors affecting this rate were examined.

83 of the patients were male (77.58%) and 24 were female (22.42%). The mean age was 46 years. The mean value of lactate level was 3.25. MPV mean value was 10.34. NLR mean value was 8.23 and Apache 2 score mean value was 22.8. The average length of stay in hospital was 11.33 days. When the intergroup mortality was evaluated in terms of the relationship between continuous variables, there was a statistically significant difference in apache 2 score. No statistically significant difference was found between age, lactate, MPV, NRL and length of hospital stay.

NRL, MPV, Lactate levels were not suitable for evaluation of trauma patients as a early prognostic factor in the first day ICU admission. The investigators think that the use of trauma scoring systems such as apache 2 related to mortality during first hospitalization in ICU is more appropriate.

Enrollment

107 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • trauvma patients

Exclusion criteria

  • systemic inflammatory diseases
  • cancer
  • renal failure
  • cardiac failure
  • serebro vascular diseases

Trial design

107 participants in 2 patient groups

living patients
Description:
living patients in intersivecare unit about 28 days
Treatment:
Other: decesased patients
deceased patients
Description:
deceased patients in intersivecare unit about 28 days
Treatment:
Other: decesased patients

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems